Finance

Cyclacel Pharmaceuticals implementing 1-for-15 reverse stock split on July 7, 2025.

by Market News Data

From Yahoo Finance: 2025-07-03 09:10:00

Cyclacel Pharmaceuticals (CYCC) plans to implement a 1-for-15 reverse stock split on July 7, 2025, with trading to start on a split-adjusted basis on The Nasdaq Capital Market under the symbol “CYCC.” The new CUSIP number for the shares will be 23254L876. Stay informed with TheFly for real-time financial news. Check out insider trading stocks on TipRanks.

Read more: Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split

You may also like